Life Sciences

Upcoming Blog Series On TransCelerate Shared Investigator Platform (SIP)

healthcare journey map

In an industry that has historically been siloed and secretive, the nonprofit collaboration known as TransCelerate BioPharma, Inc. (TransCelerate) is a clear indicator of change. It was formed in 2012 by a group of innovative thinkers and doers from a handful of leading life sciences organizations, with the mission to “collaborate across the global biopharmaceutical research and development community to identify, prioritize, design and facilitate implementation of solutions designed to drive the efficient, effective and high-quality delivery of new medicines.”

One of TransCelerate’s areas of focus is improving the site investigator experience. To that end, the group has created something called the Shared Investigator Platform (SIP), designed to serve as a single, cloud-based, digital interface for all clinical investigators conducting research for any of the TransCelerate member companies. To date, those member companies include AbbVie, Allergan, Amgen, Astellas, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, EMD Serono Merck, GlaxoSmithKline, Johnson & Johnson, Lilly, Merck & Co., Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Shionogi, and UCB.

The Digital Essentials, Part 3
The Digital Essentials, Part 3

Developing a robust digital strategy is both a challenge and an opportunity. Part 3 of the Digital Essentials series explores five of the essential technology-driven experiences customers expect, which you may be missing or not fully utilizing.

Get the Guide

The concept of the SIP is quite noble and has the potential to vastly improve the experience of investigators and site personnel working on clinical trials. But it also has many inherent challenges that should be carefully considered.

Over the next few weeks, this series of blog posts will discuss the benefits and challenges associated with adopting the SIP, and offer SIP-related recommendations for companies that are considering joining TransCelerate, as well as those that are already members.

Stay tuned! In the meantime, check out this brief video that describes a project we completed for one of the TransCelerate member companies, and fill out the form below to download our related guide, Perspectives on the TransCelerate Shared Investigator Platform.

About the Author

Marin joined the life sciences industry in 2001. Over the course of her tenure, she has held roles in clinical finance, IT, quality assurance, and validation. The diversity of her experience provides her with a unique perspective on the interconnectedness of this complex, multi-faceted industry. Marin Richeson is a lead business consultant in Perficient's life sciences practice.

More from this Author

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.